http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2013503826-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B2200-13 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H15-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H1-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H15-252 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H15-252 |
| filingDate | 2010-09-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2013-02-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2013503826-A |
| titleOfInvention | Crystallization of 4'-epidaunorubicin xHCl |
| abstract | The present invention relates to a form of crystalline 4′-epidaunorubicin hydrochloride that is stable and readily soluble, and to a process for its manufacture. This process consists of (a) a solvent A selected from the group consisting of C1 and C2 halogenated solvents and mixtures thereof; and (b) C1-C5 linear and branched alcohols and mixtures thereof. A solvent B selected from the group, and (c) a solvent C selected from the group consisting of C1-C5 linear and branched alcohols and mixtures thereof, wherein the solvent C is more than the solvent B Crystallizing 4′-epidaunorubicin hydrochloride in a solvent system comprising solvent C, which is selected to provide low solubility to 4′-epidaunorubicin hydrochloride. [Selection figure] None |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10301343-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2017514821-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20180009737-A |
| priorityDate | 2009-09-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 69.